OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Are patients with hepatocellular carcinoma and portal vein tumour thrombosis candidates for liver transplantation?
Arvinder S. Soin, Mickaël Lesurtel, Prashant Bhangui, et al.
Journal of Hepatology (2023) Vol. 78, Iss. 6, pp. 1124-1129
Open Access | Times Cited: 13
Arvinder S. Soin, Mickaël Lesurtel, Prashant Bhangui, et al.
Journal of Hepatology (2023) Vol. 78, Iss. 6, pp. 1124-1129
Open Access | Times Cited: 13
Showing 13 citing articles:
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations
Ashish Kumar, Subrat Kumar Acharya, Shivaram Prasad Singh, et al.
Journal of Clinical and Experimental Hepatology (2023) Vol. 14, Iss. 1, pp. 101269-101269
Closed Access | Times Cited: 26
Ashish Kumar, Subrat Kumar Acharya, Shivaram Prasad Singh, et al.
Journal of Clinical and Experimental Hepatology (2023) Vol. 14, Iss. 1, pp. 101269-101269
Closed Access | Times Cited: 26
Disadvantage of Viable Portal Vein Tumor Thrombosis in Liver Transplantation for Advanced Hepatocellular Carcinoma
Kun‐Ming Chan, Yin Lai, Hao‐Chien Hung, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 188-188
Open Access
Kun‐Ming Chan, Yin Lai, Hao‐Chien Hung, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 188-188
Open Access
HAIC plus lenvatinib and tislelizumab for advanced hepatocellular carcinoma with Vp4 portal vein invasion
Shuang‐Yan Tang, Feng Shi, Yi Xiao, et al.
Hepatology International (2025)
Closed Access
Shuang‐Yan Tang, Feng Shi, Yi Xiao, et al.
Hepatology International (2025)
Closed Access
Liver resection for hepatocellular carcinoma with vascular invasion: Current insights and future perspectives
Tong Yuan, Junjie Liu, Xing Lv, et al.
Oncology and Translational Medicine (2025)
Open Access
Tong Yuan, Junjie Liu, Xing Lv, et al.
Oncology and Translational Medicine (2025)
Open Access
Liver transplantation and resection in patients with hepatocellular cancer and portal vein tumor thrombosis: Feasible and effective?
Prashant Bhangui
Hepatobiliary & pancreatic diseases international (2023) Vol. 23, Iss. 2, pp. 123-128
Closed Access | Times Cited: 5
Prashant Bhangui
Hepatobiliary & pancreatic diseases international (2023) Vol. 23, Iss. 2, pp. 123-128
Closed Access | Times Cited: 5
Pharmacokinetic considerations for angiogenesis inhibitors used to treat hepatocellular carcinoma: an overview
Raffaele Borriello, Lucia Cerrito, Antonio Gasbarrini, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 11, pp. 785-794
Closed Access | Times Cited: 4
Raffaele Borriello, Lucia Cerrito, Antonio Gasbarrini, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 11, pp. 785-794
Closed Access | Times Cited: 4
Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation
Xinjun Lu, Qi Zhu, Junfeng Cai, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
Xinjun Lu, Qi Zhu, Junfeng Cai, et al.
Cancer Immunology Immunotherapy (2024) Vol. 74, Iss. 1
Open Access | Times Cited: 1
INASL Consensus on Management of HCC: Navigating an Evolving Field
Amit G. Singal, Anjana Pillai, Neehar D. Parikh
Journal of Clinical and Experimental Hepatology (2023) Vol. 14, Iss. 1, pp. 101292-101292
Closed Access | Times Cited: 2
Amit G. Singal, Anjana Pillai, Neehar D. Parikh
Journal of Clinical and Experimental Hepatology (2023) Vol. 14, Iss. 1, pp. 101292-101292
Closed Access | Times Cited: 2
Patients with hepatocellular carcinoma and portal vein tumour thrombosis after successful downstaging may be candidates for liver transplantation: A meta-analysis
Jianpeng Liu, Junjie Qian, Zhe Yang, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 5, pp. e219-e221
Closed Access | Times Cited: 2
Jianpeng Liu, Junjie Qian, Zhe Yang, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 5, pp. e219-e221
Closed Access | Times Cited: 2
Trends of liver transplantation in Asia
Ning Qi Pang, Albert C. Y. Chan, Alfred Wei Chieh Kow
Updates in Surgery (2024)
Closed Access
Ning Qi Pang, Albert C. Y. Chan, Alfred Wei Chieh Kow
Updates in Surgery (2024)
Closed Access
Insights into the 2023 multidisciplinary surgical treatment guidelines for hepatocellular carcinoma: perspectives from Italian Professional Associations
Mohamed Bouattour, Julie Devictor, Clémence Hollande
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 5, pp. 861-864
Open Access
Mohamed Bouattour, Julie Devictor, Clémence Hollande
HepatoBiliary Surgery and Nutrition (2024) Vol. 13, Iss. 5, pp. 861-864
Open Access
Expanding Indications for Liver Transplantation in the Treatment of Hepatocellular Carcinoma
Rachel Hogen, Tara M. Barry, Vijay Subramanian
Current Oncology (2024) Vol. 31, Iss. 8, pp. 4753-4761
Open Access
Rachel Hogen, Tara M. Barry, Vijay Subramanian
Current Oncology (2024) Vol. 31, Iss. 8, pp. 4753-4761
Open Access
Comparative Validation of Prediction Models for HCC Outcomes in Living Donor Liver Transplantation: Superiority of Tumor Markers to Imaging Study
H. Koh, Minyu Kang, Deok Gie Kim, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access
H. Koh, Minyu Kang, Deok Gie Kim, et al.
Journal of Gastroenterology and Hepatology (2024)
Closed Access
